Literature DB >> 12899696

Evidence for proteasome dysfunction in cytotoxicity mediated by anti-Ras intracellular antibodies.

Alessio Cardinale1, Ilaria Filesi, Sonia Mattei, Silvia Biocca.   

Abstract

Anti-Ras intracellular antibodies inhibit cell proliferation in vivo by sequestering the antigen and diverting it from its physiological location [Lener, M., Horn, I. R., Cardinale, A., Messina, S., Nielsen, U.B., Rybak, S.M., Hoogenboom, H.R., Cattaneo, A., Biocca, S. (2000) Eur. J. Biochem.267, 1196-1205]. Here we demonstrate that strongly aggregating single-chain antibody fragments (scFv), binding to Ras, induce apoptosis, and this effect is strictly related to the antibody-mediated aggregation of p21Ras. Proteasomes are quickly recruited to the newly formed aggregates, and their activity is strongly inhibited. This leads to the formation of aggresome-like structures, which become evident in the vast majority of apoptotic cells. A combination of anti-Ras scFv fragments with a nontoxic concentration of the proteasome inhibitor, lactacystin, markedly increases proteasome dysfunction and apoptosis. The dominant-negative H-ras (N17-H-ras), which is mostly soluble and does not induce aggresome formation or inhibit proteasome activity, only affects cell viability slightly. Together, these observations suggest a mechanism linking antibody-mediated Ras aggregation, impairment of the ubiquitin-proteasome system, and cytotoxicity.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12899696     DOI: 10.1046/j.1432-1033.2003.03722.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  5 in total

1.  Generating differentially targeted amyloid-beta specific intrabodies as a passive vaccination strategy for Alzheimer's disease.

Authors:  Kelly L Sudol; Michael A Mastrangelo; Wade C Narrow; Maria E Frazer; Yona R Levites; Todd E Golde; Howard J Federoff; William J Bowers
Journal:  Mol Ther       Date:  2009-07-28       Impact factor: 11.454

2.  mRNA display design of fibronectin-based intrabodies that detect and inhibit severe acute respiratory syndrome coronavirus nucleocapsid protein.

Authors:  Hsiang-I Liao; C Anders Olson; Seungmin Hwang; Hongyu Deng; Elaine Wong; Ralph S Baric; Richard W Roberts; Ren Sun
Journal:  J Biol Chem       Date:  2009-04-13       Impact factor: 5.157

3.  Tumour prevention by a single antibody domain targeting the interaction of signal transduction proteins with RAS.

Authors:  Tomoyuki Tanaka; Roger L Williams; Terence H Rabbitts
Journal:  EMBO J       Date:  2007-06-14       Impact factor: 11.598

Review 4.  Intracellular antibodies for proteomics.

Authors:  Michela Visintin; Giovanni Antonio Meli; Isabella Cannistraci; Antonino Cattaneo
Journal:  J Immunol Methods       Date:  2004-07       Impact factor: 2.303

5.  An ultra-stable cytoplasmic antibody engineered for in vivo applications.

Authors:  Hiroyuki Kabayama; Makoto Takeuchi; Naoko Tokushige; Shin-Ichi Muramatsu; Miyuki Kabayama; Mitsunori Fukuda; Yoshiyuki Yamada; Katsuhiko Mikoshiba
Journal:  Nat Commun       Date:  2020-01-17       Impact factor: 14.919

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.